Thailand cannabis is not recreationally legal, and it never was

Every "is weed legal in Thailand" search result you will find was written for a tourist deciding whether to walk into a shop. None of them answer the question a business actually needs answered: what is the licensed, revenue-generating activity you are permitted to build, and how far can it go before it becomes a Category 5 narcotics offense. Those are different questions, and conflating them is how capital gets deployed against a legal position that does not exist.

Start with the plain fact. Since 25 June 2025, cannabis flower in Thailand is a "controlled herb" under Thai traditional-medicine law. Sale requires a PT 33 prescription Certain. Recreational sale is not legal Certain. That is the entire recreational question, answered in full, and it has not changed since it was written into force. If your business model, or your diligence on someone else's, assumes an open recreational retail channel, it is built on a premise that does not exist under current law.

The narcotics boundary that actually matters

Here is the distinction most coverage gets wrong, and the one that matters for a licensing decision. Cannabis itself, the plant, is not on Thailand's narcotics list Certain. That is what allows GACP-licensed cultivation, dispensary retail under the prescription framework, and the field of activity this whole market is built on. But extracts above 0.2% THC are Category 5 narcotics Certain. Cross that concentration threshold in a product, an extraction process, or a supply chain step, and you are no longer operating in a controlled-herb framework. You are in narcotics law, with narcotics-law enforcement and narcotics-law penalties attached.

This is not a footnote. It is the line that separates a licensed edibles or tincture business from a criminal exposure, and it is a line that gets crossed by processing decisions made far downstream of the farm gate, often by people who never see the compliance paperwork. Any business plan involving concentrates, vapes, or high-potency extracts needs to treat 0.2% THC as a hard engineering constraint, not a regulatory suggestion.

What "controlled herb" does to a business model, not a shopping trip

For a tourist, the practical effect of the June 2025 shift was fewer walk-in options and a prescription requirement standing between them and a purchase. For a business, the effects compound differently:

• Every retail sale now sits downstream of a licensed medical gatekeeper. Your unit economics depend on prescription throughput, not foot traffic alone.
• The addressable retail base has already re-sorted around this constraint. Of roughly 18,433 shops operating at the 2024 peak, about 7,297 have closed as of early 2026, leaving approximately 11,136 still operating Certain. That is not a market in freefall. It is a market that shed the operators who could not survive inside a prescription-gated, lower-volume framework.
• Licensing and compliance cost is now a permanent line item, not a startup formality. The controlled-herb designation is the framework the industry will operate under going forward, not a transitional inconvenience awaiting reversal.

Which raises the question every serious investor asks next: is this the floor, or is a ban coming. It is also worth being precise about what the prescription requirement does not do. It does not require a foreign buyer to hold a Thai medical credential, and it does not shut foreign capital out of the sector. It does mean every gram sold through a compliant channel is tied to a documented medical transaction, which is a very different retail motion to design a business around than walk-in recreational sale.

The direction is entrenchment, not recriminalization

Recriminalization risk is low Likely. The regulatory trajectory since June 2025 has moved toward entrenching the medical framework, not unwinding legal cannabis altogether. The live downside for operators is not a ban. It is oversupply and price compression inside a shrinking, more disciplined retail base Likely. That is a fundamentally different risk to underwrite. A ban is a binary event you hedge by staying out. Oversupply and margin compression are structural conditions you underwrite by knowing where the market sits today.

The current size of that legal retail market is Likely, a figure no Thai authority publishes and one that requires reconstruction from the ground up. the current estimate is in the report →

How we know this

This assessment draws on the firm's own field program, conducted directly inside the industry: 850+ dispensaries visited, including 650 in Bangkok, 100+ owner and operator interviews across ten-plus nationalities, and the firm's own completion of the full legal licensing process from start to finish Certain. The regulatory reading above, including the EU-GMP certification status referenced elsewhere in our coverage, was confirmed against a live EudraGMDP register query on 02 July 2026. This is not secondhand summary of the law. It is the law as encountered by a business operating inside it.